Form4insider filings, from the source

SEC Form 4/A · accession 0001995275-26-000018

Whitehawk Therapeutics, Inc. · WHWK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
David James Lennon
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Sep 15, 2026
Accepted (ET)
Sep 18, 2026 · 4:41 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001422142

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock option (right to buy)F1$4.09Sep 15, 2026A193,957A—Sep 15, 2036Common Stock193,957193,957D
Restricted Stock UnitsF2,F3—Sep 15, 2026A193,957A——Common Stock193,957193,957D

Explanation of responses